Sparta Science Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Employees
  • 15
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $15M
Latest Deal Amount
  • Investors
  • 8

Sparta Science General Information

Description

Provider of an evidence-based training program designed to offer personalized and predictive analytics for athletes. The company's evidence-based training program provides a new way to objectively evaluate and compare athletes through technology and ensure every team member reaches their full athletic potential within an organization, enabling coaches and trainers to measure and reduce player injury risk, increasing on-field time and decreasing costs associated with injury treatment, insurance, and sidelined players.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Business/Productivity Software
Media and Information Services (B2B)
Primary Office
  • 165 A Constitution Drive
  • Menlo Park, CA 94025
  • United States
+1 (650) 000-0000

Sparta Science Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sparta Science Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B) 06-Mar-2020 $15M 000.00 0000 Completed Generating Revenue
4. Debt - General 01-May-2019 00000 000.00 Completed Generating Revenue
3. Later Stage VC (Series A) 02-Jan-2018 000 000.00 000.00 Completed Generating Revenue
2. Seed Round 10-Jul-2017 $690K $4.08M 00.000 Completed Generating Revenue
1. Seed Round 29-Jan-2017 $3.39M $3.39M 00.00 Completed Generating Revenue
To view Sparta Science’s complete valuation and funding history, request access »

Sparta Science Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 00,000,000 00.000000 00.0 00.00 00.00 00 00.00 00.000
Series A 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Seed 2 833,976 $0.000010 $0.07 $1.01 $1.01 1x $1.01 2.61%
Seed 2,867,230 $0.000010 $0.07 $0.94 $0.94 1x $0.94 8.99%
To view Sparta Science’s complete cap table history, request access »

Sparta Science Executive Team (9)

Name Title Board Seat Contact Info
Phil Wagner MD Founder, Chief Executive Officer & Board Member
Greg Olsen Ph.D Chief Technology Officer
Kelsey Holshouser Vice President, Operations
Fern Mandelbaum Advisor
Stephen Kaplan JD Advisor
You’re viewing 5 of 9 executive team members. Get the full list »

Sparta Science Board Members (11)

Name Representing Role Since
Adam Goobic Arsenal Growth Board Observer 000 0000
John Trbovich Arsenal Growth Board Observer 000 0000
Julie Maples Fyrfly Venture Partners Board Observer 000 0000
Matthew Hershenson Playground Global Board Member 000 0000
Phil Wagner MD Sparta Science Founder, Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Sparta Science Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sparta Science Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Arsenal Growth Growth/Expansion Minority 000 0000 000000 0
GSR Ventures Venture Capital Minority 000 0000 000000 0
Playground Global Venture Capital Minority 000 0000 000000 0
Fyrfly Venture Partners Venture Capital Minority 000 0000 000000 0
Qualcomm Ventures Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »